Skip to main content

IMAGEN ULTRASONICA MULTIMODAL DE ALTA RESOLUCION EN ENFERMEDADES CEREBROVASCULARES. UN ENFOQUE PRECLINICO HACIA NUEVAS APLICACIONES TRASLACIONALES.

PID2022-138013OB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dual photoacoustic/ultrasound technologies for preclinical research: current status and future trends

  • Pérez-Liva, Mailyn
  • Alonso de Leciñana, María
  • Gutiérrez-Fernández, María
  • Camacho Sosa-Días, Jorge
  • Fernández Cruza, Jorge
  • Rodríguez-Pardo, Jorge
  • García-Suárez, Iván
  • Laso-García, Fernando
  • L. Herraiz, Joaquín
  • Elvira Segura, Luis
30 páginas, 6 figuras, 2 tablas., Photoacoustic (PA) imaging, by integrating optical and ultrasound (US) modalities, combines high spatial resolution with deep tissue penetration, making it a transformative tool in biomedical research. This review presents a comprehensive analysis of the current status of dual PA/US imaging technologies, emphasising their applications in preclinical research. It details advancements in light excitation strategies, including tomographic and microscopic modalities, innovations in pulsed laser and alternative light sources, and US instrumentation. The review further explores preclinical methodologies, encompassing dedicated instrumentation, signal processing, and data analysis techniques essential for PA/US systems. Key applications discussed include the visualisation of blood vessels, micro-circulation, and tissue perfusion; diagnosis and monitoring of inflammation; evaluation of infections, atherosclerosis, burn injuries, healing, and scar formation; assessment of liver and renal diseases; monitoring of epilepsy and neurodegenerative conditions; studies on brain disorders and preeclampsia; cell therapy monitoring; and tumour detection, staging, and recurrence monitoring. Challenges related to imaging depth, resolution, cost, and the translation of contrast agents to clinical practice are analysed, alongside advancements in high-speed acquisition, artificial intelligence-driven reconstruction, and innovative light-delivery methods. While clinical translation remains complex, this review underscores the crucial role of preclinical studies in unravelling fundamental biomedical questions and assessing novel imaging strategies. Ultimately, this review delves into the future trends of dual PA/US imaging, highlighting its potential to bridge preclinical discoveries with clinical applications and drive advances in diagnostics, therapeutic monitoring, and personalised medicine., The work of Mailyn Pérez-Liva was supported in part by the Program Ramón y Cajal under Grant RYC2021-032739-I, MCIN/AEI/10.13039/501100011033, by the European Union ‘NextGenerationEU’/PRTR and by INVENTOR PID2022-137114OA-I00. Joaquin L Herraiz acknowledges support from TED2021-130592B-I00 funded by MCIN/AEI/10.13039/501100011033 and TARTAGLIA MIA.2021.M02.0005, funded by the Spanish Ministry of EADT, with funds nextGenerationEU/PRTR. Luis Elvira was supported by PID2022-138013OB-I00/ AEI/10.13039/501100011033/FEDER. María Gutiérrez-Fernández was supported by the Program Miguel Servet under Grant CPII20/00002, Carlos III Health Institute (ISCIII). Fernando Laso-García was supported by the Spanish Ministry of Health- (ISCIII) under Grant FI18/00026., Peer reviewed